Carolinas HealthCare System: Medication Management for Older
... “Systematic process of identifying and discontinuing drugs in instances in which existing or potential harms outweigh existing or potential benefits within the context of an individual patient’s care goals, current level of functioning, life expectancy, values, ...
... “Systematic process of identifying and discontinuing drugs in instances in which existing or potential harms outweigh existing or potential benefits within the context of an individual patient’s care goals, current level of functioning, life expectancy, values, ...
Click here for handouts
... respond to serotonin ● Like both ecstasy and meth, mephedrone causes the body to overheat ...
... respond to serotonin ● Like both ecstasy and meth, mephedrone causes the body to overheat ...
Number 1 - Laboratory Animal Boards Study Group
... SUMMARY: Drug addiction is characterized as a disease that causes compulsive, uncontrolled drug-seeking and taking behavior. It can be characterized by withdrawal symptoms but even in the absence of these symptoms, animals self-administer psychoactive substances for the pleasurable effects. This is ...
... SUMMARY: Drug addiction is characterized as a disease that causes compulsive, uncontrolled drug-seeking and taking behavior. It can be characterized by withdrawal symptoms but even in the absence of these symptoms, animals self-administer psychoactive substances for the pleasurable effects. This is ...
Triple C Fast Facts - Oregon Trail District
... adhere to recommended doses (containing 10 to 30 milligrams of dextromethorphan taken every 6 hours). However, abusers typically consume many times the recommended dose, which produces hallucinations and dissociative effects similar to those experienced with PCP (phencyclidine) or ketamine. While un ...
... adhere to recommended doses (containing 10 to 30 milligrams of dextromethorphan taken every 6 hours). However, abusers typically consume many times the recommended dose, which produces hallucinations and dissociative effects similar to those experienced with PCP (phencyclidine) or ketamine. While un ...
(Antiepileptic Drugs). Antiparkison Drugs
... • C-II controlled substance • Drug of choice to treat ADD, ADHD, and narcolepsy • Increases levels of neurotransmitters in the brain • Concerta is a QD dose – outer shell dissolves to release medication immediately, then drug is slowly released through pores in the tablet ...
... • C-II controlled substance • Drug of choice to treat ADD, ADHD, and narcolepsy • Increases levels of neurotransmitters in the brain • Concerta is a QD dose – outer shell dissolves to release medication immediately, then drug is slowly released through pores in the tablet ...
Central Nervous System Depressants. Anticonvulsants (Antiepileptic
... • C-II controlled substance • Drug of choice to treat ADD, ADHD, and narcolepsy • Increases levels of neurotransmitters in the brain • Concerta is a QD dose – outer shell dissolves to release medication immediately, then drug is slowly released through pores in the tablet ...
... • C-II controlled substance • Drug of choice to treat ADD, ADHD, and narcolepsy • Increases levels of neurotransmitters in the brain • Concerta is a QD dose – outer shell dissolves to release medication immediately, then drug is slowly released through pores in the tablet ...
02 02
... pressure, depending whether or not the net increase or decrease in peripheral resistance can balance the positive inotropic and chronotropic effects of adrenaline on the heart, effects which respectively increase the contractility and rate of the heart. ...
... pressure, depending whether or not the net increase or decrease in peripheral resistance can balance the positive inotropic and chronotropic effects of adrenaline on the heart, effects which respectively increase the contractility and rate of the heart. ...
orphenadrine (or-fenn-a-dreen) - DavisPlus
... ● Skeletal Muscle Relaxant: Assess patient for pain, muscle stiffness, and range of motion before and periodically throughout therapy. ● Parkinson’s Disease: Assess parkinsonian and extrapyramidal symptoms (restlessness or desire to keep moving, rigidity, tremors, pill rolling, mask-like face, shuff ...
... ● Skeletal Muscle Relaxant: Assess patient for pain, muscle stiffness, and range of motion before and periodically throughout therapy. ● Parkinson’s Disease: Assess parkinsonian and extrapyramidal symptoms (restlessness or desire to keep moving, rigidity, tremors, pill rolling, mask-like face, shuff ...
The drugs discussed in this chapter are used to alter an individual`s
... 2. Reverse sedation caused by benzodiazepine as adjuncts for general anesthesia 3. Reverse sedation produced for diagnostic tests or other medical procedures. ...
... 2. Reverse sedation caused by benzodiazepine as adjuncts for general anesthesia 3. Reverse sedation produced for diagnostic tests or other medical procedures. ...
Detox Medications
... Don’t give to a client withdrawing from heroin who is dehydrated!! Remember it drops BP!! ...
... Don’t give to a client withdrawing from heroin who is dehydrated!! Remember it drops BP!! ...
Adrenergic System Adrenoceptor Blocking Drugs
... and alpha2 receptors. In general, blockade of alpha-receptor reduces the sympathetic tone of blood vessels resulting in decreased TPR. When subjects take an alpha-blocker rise from the supine to erect posture the sympathetic system is activated via baroreceptors. The normal vasoconstrictive (alpha1 ...
... and alpha2 receptors. In general, blockade of alpha-receptor reduces the sympathetic tone of blood vessels resulting in decreased TPR. When subjects take an alpha-blocker rise from the supine to erect posture the sympathetic system is activated via baroreceptors. The normal vasoconstrictive (alpha1 ...
Adrenergic Agonists
... thus increasing blood flow to the kidneys and other viscera (see Figure 6.12). These receptors are not affected by α or β-blocking drugs. Therefore, dopamine is clinically useful in the treatment of shock, in which significant increases in sympathetic activity might compromise renal function. [Note: ...
... thus increasing blood flow to the kidneys and other viscera (see Figure 6.12). These receptors are not affected by α or β-blocking drugs. Therefore, dopamine is clinically useful in the treatment of shock, in which significant increases in sympathetic activity might compromise renal function. [Note: ...
What is mental life
... Major draining is through the inferior punctum – for maximum exposure you want to occlude the puctate to avoid loss of drug through the naso-lacrimal system. o Punctal occlusion = reduce systemic toxicity, avoid tasting the drops. Always occlude in pregnancy and when using -blockers! What if you th ...
... Major draining is through the inferior punctum – for maximum exposure you want to occlude the puctate to avoid loss of drug through the naso-lacrimal system. o Punctal occlusion = reduce systemic toxicity, avoid tasting the drops. Always occlude in pregnancy and when using -blockers! What if you th ...
Symptom Relief
... Renal: Necrosis of renal papillary with long term use Reye’s syndrome (a CNS infection relative to viral infection in children such as chicken pox or influenza) ...
... Renal: Necrosis of renal papillary with long term use Reye’s syndrome (a CNS infection relative to viral infection in children such as chicken pox or influenza) ...
Psychopharmacological interventions for ADHD
... Case reports of elevated liver enzymes and liver failure. Hematological –Leukopenia and anemia have been reported Growth Inhibition ...
... Case reports of elevated liver enzymes and liver failure. Hematological –Leukopenia and anemia have been reported Growth Inhibition ...
Psychopharmacological interventions for ADHD
... Case reports of elevated liver enzymes and liver failure. Hematological –Leukopenia and anemia have been reported Growth Inhibition ...
... Case reports of elevated liver enzymes and liver failure. Hematological –Leukopenia and anemia have been reported Growth Inhibition ...
Nicotine
... hyperpolarizes a neuron. Cl-, when nicotine binds it stimulates an action potential. ...
... hyperpolarizes a neuron. Cl-, when nicotine binds it stimulates an action potential. ...
9-13-04 Factors Affecting Action of Drugs
... • Main organ of transformation is liver • Drug microsomal metabolizing system or cytochrome P450 system • Converts lipid soluble compounds to water soluble – Easily eliminated in the urine ...
... • Main organ of transformation is liver • Drug microsomal metabolizing system or cytochrome P450 system • Converts lipid soluble compounds to water soluble – Easily eliminated in the urine ...
What is the most effective treatment for ADHD in children?
... Several short-term reviews and meta-analyses show that side effects from stimulant medications are mild and have short duration.5 More long-term studies are required to evaluate effects on growth. RCTs have limited power to detect rare adverse events that may be better detected by large observationa ...
... Several short-term reviews and meta-analyses show that side effects from stimulant medications are mild and have short duration.5 More long-term studies are required to evaluate effects on growth. RCTs have limited power to detect rare adverse events that may be better detected by large observationa ...
Substance related disorders
... use manifested by recurrent and significant adverse consequences related to repeated use of the substance, as manifested by one (or more) of the following, occurring within a 12-month period: A. Recurrent substance use resulting in failure to fulfill major role at work, school, or home. B. Recurrent ...
... use manifested by recurrent and significant adverse consequences related to repeated use of the substance, as manifested by one (or more) of the following, occurring within a 12-month period: A. Recurrent substance use resulting in failure to fulfill major role at work, school, or home. B. Recurrent ...
Presentation by Dr. Nora Volkow of NIDA
... Despite increases in ART incidence of HIV in USA has remained stable at ∼56,300 new infections per year. This is likely to reflect in part failure to treat those with SUD. Of the 1.1 M individuals living with HIV in the US, 21% are estimated to be unaware of their HIV infection. Undetected cases ar ...
... Despite increases in ART incidence of HIV in USA has remained stable at ∼56,300 new infections per year. This is likely to reflect in part failure to treat those with SUD. Of the 1.1 M individuals living with HIV in the US, 21% are estimated to be unaware of their HIV infection. Undetected cases ar ...
Document
... KD= the concentration of drug required to saturate 50% of the receptors Most effective drugs have KDs in the micromolar (10-6) to nanomolar (10-9) range. Signal transduction: the process where the binding of a drug to its receptor initiates a cascade of biochemical events that result in the physiol ...
... KD= the concentration of drug required to saturate 50% of the receptors Most effective drugs have KDs in the micromolar (10-6) to nanomolar (10-9) range. Signal transduction: the process where the binding of a drug to its receptor initiates a cascade of biochemical events that result in the physiol ...
Aller-Chlor - DavisPlus
... Absorption: Well absorbed following oral and parenteral administration. Distribution: Widely distributed. Minimal amounts excreted in breast milk. Crosses the blood-brain barrier. ...
... Absorption: Well absorbed following oral and parenteral administration. Distribution: Widely distributed. Minimal amounts excreted in breast milk. Crosses the blood-brain barrier. ...
Major Depression PPT
... Residual symptoms put patients at high risk of relapse and recurrence – Patients with residual symptoms after medication treatment are 3.5 times more likely to relapse compared to those fully recovered (Judd et al, 1998) – This risk is greater than the risk associated with having ≥ 3 prior depressiv ...
... Residual symptoms put patients at high risk of relapse and recurrence – Patients with residual symptoms after medication treatment are 3.5 times more likely to relapse compared to those fully recovered (Judd et al, 1998) – This risk is greater than the risk associated with having ≥ 3 prior depressiv ...
Drugs Of Abuse - Calgary Emergency Medicine
... • 1995: CNS GHB receptors discovered, solidifying GHB’s status as a neurotransmitter • 1997: FDA issues second warning against GHB ...
... • 1995: CNS GHB receptors discovered, solidifying GHB’s status as a neurotransmitter • 1997: FDA issues second warning against GHB ...
Stimulant
Stimulants (also referred to as psychostimulants) are psychoactive drugs that induce temporary improvements in either mental or physical functions or both. Examples of these kinds of effects may include enhanced alertness, wakefulness, and locomotion, among others. Due to their rendering a characteristic ""up"" feeling, stimulants are also occasionally referred to as ""uppers"". Depressants or ""downers"", which decrease mental and/or physical function, are in stark contrast to stimulants and are considered to be their functional opposites. Stimulants are widely used throughout the world as prescription medicines and without prescription both as legal substances and illicit substances of recreational use or abuse.